News

Main Line Psychiatric Practice Expands Comprehensive Mental Health Care for Autism and ADHD

Psychiatric Associates of Pennsylvania Addresses Critical Gap in Neurodevelopmental Mental Health Services NARBERTH, PA / ACCESS Newswire / November 24,…

1 month ago

AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care

Pilot Project to Explore AI-Driven ECG Signal Processing and Predictive Deterioration Models in Pediatric Cardiac Care TORONTO, ON / ACCESS…

1 month ago

AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care

Pilot Project to Explore AI-Driven ECG Signal Processing and Predictive Deterioration Models in Pediatric Cardiac Care TORONTO, ON / ACCESS…

1 month ago

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates

German Federal Cartel Office clearance obtained for the planned BioNTech - CureVac transaction announced on June 12, 2025, marking an…

1 month ago

Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes

LAVAL, QC / ACCESS Newswire / November 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health")…

1 month ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

ST. LOUIS, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for…

1 month ago

OneMedNet to Showcase Transformative New Platform at RSNA 2025

MINNEAPOLIS, Nov. 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the curator and provider of the largest global live,…

1 month ago

Clearmind Medicine’s Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review

Vancouver, Canada, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

1 month ago

Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform

Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug ClassesMELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq…

1 month ago

Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm…

1 month ago